© 2023 Western New York Public Broadcasting Association

140 Lower Terrace
Buffalo, NY 14202

Mailing Address:
Horizons Plaza P.O. Box 1263
Buffalo, NY 14240-1263

Buffalo Toronto Public Media | Phone 716-845-7000
WBFO Newsroom | Phone: 716-845-7040
Your NPR Station
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Some Dementia Patients Increasingly Given Antipsychotics, Study Finds

Residents walk the halls at the Easton Home in Easton, Pa.
Matt Rourke
/
AP

A new study from the AARP Public Policy Institute finds that dementia patients living at home or in assisted living facilities are increasingly being given antipsychotic drugs. This is despite the fact that antipsychotics are not approved to treat dementia. They're intended to treat serious mental illnesses such as schizophrenia and bipolar disorder. In fact, the drugs carry what's known as a black box warning that antipsychotic drug use by older dementia patients can increase the risk of death.

The study used data from Medicare Advantage plans from 2012 to 2015. At the beginning of the study, 12.6 percent of dementia patients living at home or in assisted living had prescriptions for antipsychotic drugs. However, by the end of the AARP's study period, 13.4 percent of dementia patients living at home or in assisted living had prescriptions for antipsychotic drugs. This is an increase of more than 6 percent.

This runs counter to the trend in nursing homes, where the prescribing of antipsychotic drugs for dementia patients has declined by more than a third. This was largely due to a federal government campaign to reduce the use of the drugs in skilled nursing facilities. At 15.4 percent, there's still a higher rate of antipsychotic use on dementia patients in nursing homes than outside of them. The federal government tracks each nursing home's rate of antipsychotic use and makes that information publicly available on the website Nursing Home Compare. The GAO has recommended that the federal government pay more attention to reducing the use of antipsychotic drugs among all dementia patients, not just those in nursing homes.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Ina Jaffe is a veteran NPR correspondent covering the aging of America. Her stories on Morning Edition and All Things Considered have focused on older adults' involvement in politics and elections, dating and divorce, work and retirement, fashion and sports, as well as issues affecting long term care and end of life choices. In 2015, she was named one of the nation's top "Influencers in Aging" by PBS publication Next Avenue, which wrote "Jaffe has reinvented reporting on aging."